Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

Gelijkaardige items

• Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
  door: Jazayeri-Tehrani, Seyed Ali, et al.
  Gepubliceerd in: (2019)
• Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
  door: Daneshi-Maskooni, Milad, et al.
  Gepubliceerd in: (2018)
• The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
  door: Daneshi-Maskooni, Milad, et al.
  Gepubliceerd in: (2017)
• Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
  door: Daneshi-Maskooni, Milad, et al.
  Gepubliceerd in: (2019)
• Nanocurcumine Ameliorates Lipopolysaccharide-induced Depressive-like Behavior in Mice
  door: Nahid Fakhraei, et al.
  Gepubliceerd in: (2018-04-01)